Uniportal video-assisted thoracoscopic drainless sympathectomy for palmar and palmo-plantar hyperhidrosis: an institutional experience

• Published in: Cardiothoracic Surgeon 2020-09, Vol.28 (1), Article 20
• Main Authors: El-Hag-Aly, Mohammed Ahmed, Soliman, Rafik Fekry, Zaid, Nehad Abdo, Eldesouky, Mahmoud Said, Bakoush, Mohamed Mordy, Hagag, Mohamed Gamal
• Format: Article
• Language: English
• Subjects: Anesthesia; Body mass index; Botulinum toxin; Cameras; Chest tubes; Comparative analysis; Females; Hospitals; Hyperhidrosis; Medical research; Medicine; Medicine & Public Health; Medicine, Experimental; Ostomy; Patients; Pneumothorax; Statistical analysis; Surgery; Surgical outcomes; Topical medication; Ventilation
• ISSN: 2662-2203; 2636-333X; 2662-2203
• DOI: 10.1186/s43057-020-00030-3

Background Primary hyperhidrosis (PH) still impacts negatively the patient’s quality of life (QoL). Progressively, it leads to poorer QoL regardless of gender. The endoscopic thoracic sympathectomy has been used safely and effectively for control of palmar hyperhidrosis, but it is still questionable in palmo-plantar type. We assessed the benefits of uniportal drainless thoracoscopic sympathectomy (UDTS) for palmo-plantar hyperhidrosis patients compared to palmar ones. This prospective study comprised 213 consecutive patients with PH. They underwent bilateral simultaneous UDTS. We used the Hyperhidrosis Disease Severity Scale (HDSS) scoring system for assessment of QoL pre- and postoperatively. Follow-up was continued for 1-year that was aiming to detect the QoL improvement, recurrence, and compensatory hyperhidrosis (CH). Results All patients experienced immediate complete resolution of hyperhidrosis postoperatively. Recurrence was encountered in one patient during the first 6 months. All patients had improved QoL postoperatively, but at the end of 1-year follow-up, 2.8% of patients were still suffering moderate to severe impaired QoL. Mean hospital stay was 31.79 ± 17.5 h. We found significant longer hospital stay in palmar group than palmo-plantar group. There was no significant difference between both groups in neither operative time, recurrence, nor CH. Conclusions UDTS offers better QoL for patients with PH even the palmo-plantar type. The palmo-plantar type benefits similarly to the palmar type in terms of comparable postoperative QoL and CH incidence.